In hepatocellular carcinoma (HCC), TRIM25 has been found to target and degrade Keap1, consequently activating Nrf2 and fostering HCC cell proliferation by modulating the UPR signaling pathway and ERAD. Here, TRIM25 is linked to hepatocellular carcinoma.